DUBLIN--(BUSINESS WIRE)--The "United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)" report has been added to Research and Markets' offering.
The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their efforts to maintain significant growth margins by tapping into markets of major unmet medical needs. United States Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing pain related health ailment issue. The widespread availability of drugs and the advent of new drugs have accelerated the pace of growth in the market.
The pain management market is fueled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post-operative pain relief markets. The largest segment of the United States pain management market is the arthritis while pediatric pain is the smallest segment for the pain management. The cancer pain management market is the most rapidly growing segment of the United States pain management market.
This report titled United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development) provides a comprehensive assessment of the fast-evolving, high-growth of United States Pain Management Therapeutics Sector.
This report with 45 Figures and 3 Tables studies in details:
- United States Pain Management Therapeutics Market and Forecast (2007 - 2022)
- United States Pain Management Patients Volume and Forecast (2007 - 2022)
- 50 Company's Pipeline Product Analysis (By Product, Indication, Phase of Development)
- United States Pain Management Therapeutics Market - Driving Factors & Challenges
10 Pain Management Segments covered in the report are as follows
- Arthritis Pain
- Migraine Pain
- Post-Operative Pain
- Cancer Pain
- Neuropathic Pain
- Back Pain
- Fibromyalgia Pain
- Facial Pain
- Pediatric Pain
- Obstetrical Pain
Company Wise Pipeline Analysis
- Teva Pharmaceutical
- Astellas Pharmaceuticals Inc.
- Durect Corporation
- Pfizer
- AbbVie Inc.
- AcelRx Pharmaceuticals, Inc.
- Axsome Therapeutics, Inc
- BioDelivery Sciences International
- Cara Therapeutics
- COLLEGIUM Pharmaceutical Inc.
- Centrexion Therapeutics
- Daiichi Sankyo Company Ltd.
- Depomed Inc.
- Eli Lilly and Company
- Endo Pharmaceuticals Inc.
- EpiCept
- FemmePharma
- Flexion Therapeutics Inc.
- Galapagos NV
- Heron Therapeutics
- Mesoblast Ltd
- Novartis International AG
- Nuvo Pharmaceuticals
- Nektar Therapeutics
- NeurAxon
- Newron Pharmaceuticals
- Olatec Industries
- Otsuka Pharmaceutical
- Recro Pharma, Inc
- Relmada Therapeutics, Inc
- Scintilla Pharmaceuticals, Inc.
- Trevena Inc.
- Trigemina, Inc.
- WEX Phamaceuticals Inc
- Zynerba Pharmaceuticals, Inc.
Key Topics Covered:
1. Executive Summary
2. United States - Pain Management Therapeutics Market
3. United States - Pain Management Patient Population
4. United States - Pain Management Therapeutics Market Share
5. United States - Segment Wise Pain Management Therapeutics Market & Population
6. Pain Management Therapeutics Pipeline Products - By Company, Indication, Phase of Development
7. United States Pain Management Therapeutics Market - Driving Factors
8. United States Pain Management Therapeutics Market - Challenges
For more information about this report visit https://www.researchandmarkets.com/research/vnj2md/united_states
